Day: March 29, 2021

CE COMMUNIQUE NE PEUT ETRE ENVOYE, PUBLIE OU DISTRIBUE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS, EN AUSTRALIE, AU CANADA OU AU JAPON. CE COMMUNIQUE NE CONSTITUE PAS UN DOCUMENT D’OFFRE ET A UN CARACTERE PUREMENT INFORMATIF. PARIS, 29 mars 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (Nasdaq: CLLS – Euronext Growth: ALCLS), société de biotechnologie de stade clinique utilisant ses propres technologies pour développer des produits de pointes fondés sur les cellules CAR-T allogéniques ingénierées (UCART) dans le domaine de l’immuno-oncologie, annonce la mise en place ce jour d’un programme de financement en fonds propres dit « At-the-market » (le « Programme ATM ») lui permettant d’émettre et de placer auprès d’investisseurs éligibles, en une ou plusieurs fois, des actions ordinaires sous la forme d’American Depositary Shares...

DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, HONKONG, JAPAN, KANADA, NYA ZEELAND, SINGAPORE, SYDAFRIKA, USA ELLER NÅGON ANNAN JURISDIKTION DÄR SÅDAN ÅTGÄRD HELT ELLER DELVIS ÄR FÖREMÅL FÖR LEGALA RESTRIKTIONER. DETTA PRESSMEDDELANDE UTGÖR INTE ETT ERBJUDANDE OM, ELLER INBJUDAN TILL, ATT FÖRVÄRVA, ELLER TECKNA NÅGRA, VÄRDEPAPPER I CORLINE BIOMEDICAL AB I NÅGON JURISDIKTION. SE ÄVEN AVSNITTET ”VIKTIG INFORMATION” NEDAN. Pressmeddelande Corline Biomedical AB556417–07432021-03-29 Corline har genomfört en riktad emission om cirka 35,5 miljoner kronor Corline Biomedical AB (publ) (“Corline” eller “Bolaget”) har, i enlighet med vad som offentliggjordes i Bolagets pressmeddelande den 29 mars kl 17:31, framgångsrikt genomfört en riktad kontant nyemission om 3 300 000...

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — Pinehurst Capital I Inc. (TSXV: PHT.P) (the “Corporation” or “Pinehurst“), a capital pool company listed on the TSX Venture Exchange (“TSXV“), and further to its previously proposed qualifying transaction (the “Transaction“) with Silver Bullet Mines Inc. (“SBMI”), is pleased to provide an update on the Transaction and associated financing (the “SBMI Financing”). Pinehurst and SBMI made minor amendments to the definitive agreement between them. The amendments:extend the outside date to closing the Transaction to April 30, 2021; and change the definition of “SBMI Financing” to mean one or more non-brokered private placements of securities of SBMI (but, for greater certainty, excluding the SBMI Convertible Note) for aggregate gross proceeds...

PITTSBURGH, March 29, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced participation in two upcoming virtual conferences. Details for the presentations are as follows:Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare DiseaseDate:   Thursday, April 1Time:   Krystal leadership will participate in a panel discussion at 4:00pm ET     2021 Virtual Cell & Gene Meeting on the MediterraneanDate:   Tuesday, April 6 – Friday, April 9Time:   Company presentations will be available to view on-demand throughout the entirety of the conference. Please visit www.meetingonthemed.com for full information, including registration.About Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS) is a pivotal-stage gene...

      Decrease in Pretax Net Income Offset by a Reduction in Income Tax ExpenseNo Change to Originally Reported Net Income or Earnings Per Share Calculations OSWEGO, N.Y., March 29, 2021 (GLOBE NEWSWIRE) — Pathfinder Bancorp, Inc. (“Company”) (NASDAQ: PBHC), the holding company for Pathfinder Bank (“Bank”) issued an update to its earnings release furnished on a Current Report on Form 8-K on February 1, 2020 (the “Original Press Release”) reporting its financial results at and for the three and twelve months ended December 31, 2020. This updated Press Release (the “Updated Press Release”) is being furnished to revise pretax net income and related financial information for the three and twelve months ended December 31, 2020. Two revisions to pretax net income were made related to loan interest income and operating expenses that reduced...

GLYFADA, Greece, March 29, 2021 (GLOBE NEWSWIRE) — Globus Maritime Limited (“Globus,” the “Company,” “we,” or “our”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that the Company’s annual report on Form 20-F that contains the Company’s audited financial statements for the fiscal year ended December 31, 2020 was filed today with the Securities and Exchange Commission, and may be found on the Company’s website at www.globusmaritime.gr under Investor Relations. Alternatively, shareholders may receive a hard copy of the 2020 Annual Report on Form 20-F, free of charge, by request to Globus’ Investor Relations Advisor at: Capital Link Inc.230 Park Avenue, Suite 1536New York, NY 10169 USATel: (+) 1 212 661 7566Email: globus@capitallink.com About Globus Maritime Limited Globus is an integrated dry bulk...

Adm. direktør Michael Hove samt bestyrelsesmedlem Jakob Have har dd. meddelt selskabet, at de ønsker at udnytte deres warranter iht. warrantprogram af 15 juni 2018, hvilket giver dem ret til at tegne følgende antal aktier til 1,44.Michael Hove: 2.318.631 aktier Jakob Have 275.000 aktierSelskabet vil sælge i alt 2.593.631 aktier fra sin egenbeholdning. Kontakt:Evt. spørgsmål til denne meddelelse kan rettes til CEO Michael Hove på 28126609 eller mail mh@sca-invgroup.dk Venlig hilsenBestyrelsen Vedhæftede filer

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) — VORNADO REALTY TRUST (NYSE: VNO) announced today that it has completed a $350 million refinancing of 909 Third Avenue, a 1.4 million square foot Manhattan office building. The interest only loan bears a fixed rate of 3.23% and matures in April 2031. The loan replaces the previous $350 million loan that bore interest at a fixed rate of 3.91% and was scheduled to mature in May 2021. Vornado Realty Trust is a fully-integrated equity real estate investment trust. CONTACT Thomas Sanelli(212) 894-7000 Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance...